Singapore markets open in 40 minutes

PT Indofarma Tbk (INAF.JK)

Jakarta - Jakarta Delayed price. Currency in IDR
Add to watchlist
0.0000-130.0000 (-100.00%)
At close: 04:00PM WIB
Currency in IDR

Valuation measures4

Market cap (intra-day) 415.30B
Enterprise value 942.22B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.61
Price/book (mrq)6.53
Enterprise value/revenue 1.38
Enterprise value/EBITDA -1.98

Trading information

Stock price history

Beta (5Y monthly) -0.03
52-week change 3-81.02%
S&P500 52-week change 323.57%
52-week high 3725.0000
52-week low 30.0000
50-day moving average 3311.7800
200-day moving average 3464.4350

Share statistics

Avg vol (3-month) 3200.79k
Avg vol (10-day) 3186.06k
Shares outstanding 53.1B
Implied shares outstanding 63.17B
Float 8227.55M
% held by insiders 188.01%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 403 May 2013
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -63.81%
Operating margin (ttm)-78.72%

Management effectiveness

Return on assets (ttm)-18.77%
Return on equity (ttm)-397.64%

Income statement

Revenue (ttm)684.91B
Revenue per share (ttm)220.99
Quarterly revenue growth (yoy)-75.30%
Gross profit (ttm)N/A
EBITDA -479.07B
Net income avi to common (ttm)-437.05B
Diluted EPS (ttm)-141.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)209.81B
Total cash per share (mrq)67.7
Total debt (mrq)771.72B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.71
Book value per share (mrq)-33.99

Cash flow statement

Operating cash flow (ttm)-254.29B
Levered free cash flow (ttm)-11.3B